Health
Rare cancer drug to be subsidised – The Transcontinental
A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme….
A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme.
People suffering from advanced gastrointestinal stromal tumour will be able to buy the drug Qinlock for at most $41.30 per script…
Continue Reading
-
Business21 hours agoBell Potter names cheap ASX dividend shares to buy now
-
Noosa News23 hours agoWhy buying a home in this surprise suburb could save you $400,000
-
Noosa News14 hours agoComing Soon: Marlowe
-
General19 hours agoAdelaide Crows star Izak Rankine at risk of AFL investigation for alleged incident in Collingwood win